We are live on ! Find out more
ADEF

ABS Direct Equity Fund Portfolio holdings

AUM $159M
1-Year Est. Return 34.17%
This Fund
S&P 500
This Quarter Est. Return
+29%
1 Year Est. Return
+34.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$159M
AUM Growth
+$28.3M
Cap. Flow
-$23.9M
Cap. Flow %
-15.02%
Top 10 Hldgs %
40.37%
Holding
151
New
42
Increased
21
Reduced
43
Closed
40

Top Buys

Rank Stock Value
1
GGAL icon
Galicia Financial Group
GGAL
+$3.19M
2
TEO icon
Telecom Argentina
TEO
+$2.94M
3
SRE icon
Sempra
SRE
+$2.33M
4
BMA icon
Banco Macro
BMA
+$2.01M
5
LRN icon
Stride
LRN
+$1.84M

Top Sells

Rank Stock Value
1
STNE icon
StoneCo
STNE
+$5.76M
2
INTR icon
Inter&Co
INTR
+$4.2M
3
NU icon
Nu Holdings
NU
+$3.51M
4
CLBT icon
Cellebrite
CLBT
+$3.44M
5
XP icon
XP
XP
+$2.46M

Sector Composition

Rank Sector Weight
1 Technology 32.32%
2 Consumer Discretionary 16.86%
3 Industrials 16.03%
4 Materials 6.4%
5 Financials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
76
Honeywell
HON
$64.5B
$437K 0.27%
+448
New +$100K
HONA
77
Honeywell Aerospace
HONA
$50.2B
$431K 0.27%
+442
New +$97.5K
CSX icon
78
CSX Corp
CSX
$90.1B
$409K 0.26%
48
-8,552
-99% -$386K
EMBJ
79
Embraer S.A. ADS
EMBJ
$13.2B
$396K 0.25%
+6,200
New +$381K
V icon
80
Visa
V
$701B
$384K 0.24%
343
-777
-69% -$249K
AAPL icon
81
Apple
AAPL
$4.84T
$376K 0.24%
289
-1,011
-78% -$289K
CTSH icon
82
Cognizant
CTSH
$28.5B
$360K 0.23%
+9,300
New +$490K
GH icon
83
Guardant Health
GH
$23.6B
$345K 0.22%
150
-2,150
-93% -$234K
AMX icon
84
America Movil
AMX
$69.4B
$338K 0.21%
13,000
-24,800
-66% -$652K
RVMD icon
85
Revolution Medicines
RVMD
$43.9B
$337K 0.21%
187
-1,613
-90% -$236K
WM icon
86
Waste Management
WM
$86.8B
$334K 0.21%
223
-1,277
-85% -$284K
SHW icon
87
Sherwin-Williams
SHW
$78.5B
$317K 0.2%
344
-576
-63% -$184K
SYNA icon
88
Synaptics
SYNA
$3.81B
$311K 0.2%
+124
New +$14K
ESI icon
89
Element Solutions
ESI
$7.75B
$310K 0.2%
+48
New +$1.99K
TWLO icon
90
Twilio
TWLO
$37.2B
$309K 0.19%
206
-1,294
-86% -$229K
CYTK icon
91
Cytokinetics
CYTK
$9.64B
$273K 0.17%
+85
New +$6.1K
MIRM icon
92
Mirum Pharmaceuticals
MIRM
$6.1B
$246K 0.15%
117
-1,983
-94% -$199K
LLY icon
93
Eli Lilly
LLY
$1.01T
$240K 0.15%
1,199
+999
+500% +$1.02M
LNTH icon
94
Lantheus
LNTH
$6.58B
$233K 0.15%
+111
New +$10.3K
DNTH icon
95
Dianthus Therapeutics
DNTH
$5.86B
$195K 0.12%
97
-1,903
-95% -$166K
RGEN icon
96
Repligen
RGEN
$9.86B
$191K 0.12%
+136
New +$16.7K
SYRE icon
97
Spyre Therapeutics
SYRE
$8.02B
$186K 0.12%
89
-2,711
-97% -$198K
COGT icon
98
Cogent Biosciences
COGT
$5.68B
$182K 0.11%
39
-4,661
-99% -$163K
CRL icon
99
Charles River Laboratories
CRL
$13B
$181K 0.11%
227
-773
-77% -$138K
SMTC icon
100
Semtech
SMTC
$14.1B
$178K 0.11%
162
-938
-85% -$123K

Similar funds

ABS Direct Equity Fund's Q2 2026 Portfolio in Review

As of Q2 2026, ABS Direct Equity Fund held 151 positions worth $159M, up 22% from $131M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

ABS Direct Equity Fund withdrew a net $23.9M in Q2 2026, closing 40 positions and reducing 43 holdings. Its most notable exit was StoneCo, an estimated $5.76M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, ABS Direct Equity Fund opened a new position in Galicia Financial Group worth $3.39M.

  • ABS Direct Equity Fund's largest Q2 2026 buy was Galicia Financial Group: 67,845 shares worth $3.39M.
  • ABS Direct Equity Fund added most to Sempra in Q2 2026, an estimated $2.33M increase.
  • ABS Direct Equity Fund's biggest Q2 2026 reduction was Euronet Worldwide, cutting an estimated $2.09M.
  • ABS Direct Equity Fund fully exited StoneCo in Q2 2026, selling an estimated $5.76M.
  • ABS Direct Equity Fund's ten largest holdings make up 40% of its $159M portfolio in Q2 2026.
  • ABS Direct Equity Fund opened 42 new positions and closed 40 in Q2 2026.
  • ABS Direct Equity Fund's portfolio value rose 22% quarter-over-quarter to $159M.

Based on ABS Direct Equity Fund's 13F filing for Q2 2026, filed 13 Aug 2026.